San Carlos, CA ; 2/20/20
Amount Funded: $40 Million
Type: Series B
Lead Investor: Andreeseen Horowitz
Participating Investor(s): Khosla Ventures, Founders Fund, Beast Ventures, Thirty5 Venturers, Sea Lane Venturers, SciFi VC
Total Funding to Date: $58 Million
Company Description: “Founded in 2015 by serial entrepreneur Jeff Kaditz, Dr. Michael Snyder and Dr. Garry Choy, Q Bio gives you a deeper understanding of your body and how it’s changing, so you have more control over your health. Q Bio’s platform is a quantitative, clinically-relevant assessment of personal human health. We believe in making preventive health available to everyone so that treatable diseases no longer take lives.”
What funding will be used for:
Improve its proprietary platform and technology to make their preventive health services faster, better and more affordable.
“Since my own misdiagnoses over a decade ago, I’ve imagined a day when everything about a person’s body could be quickly measured, shared and analyzed. It took time but Q Bio was born,” said Jeffrey Kaditz, co-founder and CEO of Q Bio. “We are thrilled to have our current investors continue to share our vision and excitement for what is possible in the field of preventive health.”
-Jeffrey Kadiz, co-founder, CEO, QBio
- Joining QBio’s Board of Directors are Vijay Pande, General Partner, Andreessen Horowitz, and Vinod Khosla, Khosla Ventures.
- Clarissa Shen, COO, QBio, will join the board as an observer.
Data provided by respective company (unless otherwise noted) and researched by StartupsOne for accuracy.